Liver Cancer treatment

A pharmaceutical company has come up with a treatment that shrinks the size of tumors in the liver and stabilizes the disease. This treatment does not kill healthy cells like treatments do such as chemotherapy. But even though this treatment is helpful by shrinking the size of tumors, results show that the average survival rate was still only 9 months. In some of the trials patients had this treament shrink their tumors as much as 50%. Another advantage of this, is the side effects are minimal. As of now the drug is considered to be an orphan drug, meaning only used to treat small amounts of patients.